Akoya Biosciences, Inc. (AKYA)
Jul 8, 2025 - AKYA was delisted (reason: acquired by QTRX)
1.290
0.00 (0.00%)
Inactive · Last trade price on Jul 7, 2025

Akoya Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-47.53-55.37-63.32-70.64-42.94-16.71
Depreciation & Amortization
7.47.658.897.154.793.82
Loss (Gain) From Sale of Assets
---0.08--
Asset Writedown & Restructuring Costs
-2.97----
Loss (Gain) From Sale of Investments
-1.3-1.66-0.01-0.22--
Stock-Based Compensation
8.999.3110.447.434.040.48
Provision & Write-off of Bad Debts
0.60.92----
Other Operating Activities
3.885.967.582.552.63.18
Change in Accounts Receivable
1.142.3-7.27-0.29-2.976.7
Change in Inventory
-1.55-9.86-6.33-5.37-4.63-0.68
Change in Accounts Payable
-0.46-3.021.151.194.36-3.05
Change in Unearned Revenue
-0.24-0.261.492.580.96-0.43
Change in Other Net Operating Assets
-1.41-3.05-3.522.04-2.28-0.15
Operating Cash Flow
-30.49-44.1-50.9-53.5-36.07-6.84
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Capital Expenditures
-1.85-2.46-3.65-7.36-5.09-3.3
Sale of Property, Plant & Equipment
---0.06--
Investment in Securities
42.66-21.67-6.77-10.02
Investing Cash Flow
40.81-24.053.35-14.08-5.096.73

Financing Activities

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Long-Term Debt Issued
--11.2531.25-34.98
Long-Term Debt Repaid
--1.02-0.68-0.62-0.32-25.19
Net Debt Issued (Repaid)
-1.02-1.0210.5730.63-0.329.79
Issuance of Common Stock
0.060.0948.310.45138.950.12
Repurchase of Common Stock
-0.14-0.21-0.09---
Other Financing Activities
-1.91-2.06-1.95-2.35-1.59-4.42
Financing Cash Flow
-3.01-3.2156.8428.73137.045.49

Net Cash Flow

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Cash Flow
7.31-71.369.29-38.8595.875.37

Free Cash Flow

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Free Cash Flow
-32.34-46.56-54.55-60.86-41.16-10.14
Free Cash Flow Growth
------
Free Cash Flow Margin
-40.45%-57.01%-56.45%-81.29%-74.95%-23.89%
Free Cash Flow Per Share
-0.65-0.94-1.23-1.61-1.53-4.28
Levered Free Cash Flow
-15.14-26.52-34.04-34.24-26.04-5.5
Unlevered Free Cash Flow
-8.7-20-28.56-31.39-24.1-3.8

Additional Metrics

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash Interest Paid
9.069.187.653.482.672.25
Cash Income Tax Paid
0.090.090.06---
SEC Filings: 10-K · 10-Q